Therapeutic Drug Monitoring Pipeline Report Including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update

Therapeutic Drug Monitoring Pipeline Report Including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update


Summary

GlobalData's Medical Devices sector report, “Therapeutic Drug Monitoring Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Therapeutic Drug Monitoring pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Therapeutic drug monitoring tests include reagents and test kits intended to measure different types of therapeutic drugs from samples ranging from serum/blood, urine, hair and sweat.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Therapeutic Drug Monitoring under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Therapeutic Drug Monitoring and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Therapeutic Drug Monitoring under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


  • About GlobalData
  • Introduction
    • Therapeutic Drug Monitoring Overview
  • Products under Development
    • Therapeutic Drug Monitoring - Pipeline Products by Stage of Development
      • Table Figure 1: Therapeutic Drug Monitoring - Pipeline Products by Stage of Development
      • Table Therapeutic Drug Monitoring - Pipeline Products by Stage of Development
    • Therapeutic Drug Monitoring - Pipeline Products by Segment
      • Table Figure 2: Therapeutic Drug Monitoring - Pipeline Products by Segment
      • Table Therapeutic Drug Monitoring - Pipeline Products by Segment
    • Therapeutic Drug Monitoring - Pipeline Products by Territory
      • Table Figure 3: Therapeutic Drug Monitoring - Pipeline Products by Territory
      • Table Therapeutic Drug Monitoring - Pipeline Products by Territory
    • Therapeutic Drug Monitoring - Pipeline Products by Regulatory Path
      • Table Figure 4: Therapeutic Drug Monitoring - Pipeline Products by Regulatory Path
      • Table Therapeutic Drug Monitoring - Pipeline Products by Regulatory Path
    • Therapeutic Drug Monitoring - Pipeline Products by Estimated Approval Date
      • Table Figure 5: Therapeutic Drug Monitoring - Pipeline Products by Estimated Approval Date
      • Table Therapeutic Drug Monitoring - Pipeline Products by Estimated Approval Date
    • Therapeutic Drug Monitoring - Ongoing Clinical Trials
      • Table Figure 6: Therapeutic Drug Monitoring - Ongoing Clinical Trials
      • Table Therapeutic Drug Monitoring - Ongoing Clinical Trials
  • Therapeutic Drug Monitoring - Pipeline Products under Development by Companies
    • Therapeutic Drug Monitoring Companies - Pipeline Products by Stage of Development
      • Table Therapeutic Drug Monitoring Companies - Pipeline Products by Stage of Development
    • Therapeutic Drug Monitoring - Companies Pipeline Products by Stage of Development
      • Table Therapeutic Drug Monitoring - Companies Pipeline Products by Stage of Development
  • Therapeutic Drug Monitoring Companies and Product Overview
    • 20/20 GeneSystems Inc Company Overview
      • 20/20 GeneSystems Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table 20/20 GeneSystems Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table PredicTOR Breast Test - Product Status
        • Table PredicTOR Breast Test - Product Description
    • Abbott Diagnostics Company Overview
      • Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
        • Table Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
        • Table Methotrexate Chemiluminescent Assay - Product Status
        • Table Methotrexate Chemiluminescent Assay - Product Description
    • Adaptive Biotechnologies Corp Company Overview
      • Adaptive Biotechnologies Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Adaptive Biotechnologies Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Immune System Profiling - Measure Of Vaccine Efficacy - Product Status
        • Table Immune System Profiling - Measure Of Vaccine Efficacy - Product Description
    • Affinergy LLC Company Overview
      • Affinergy LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Affinergy LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Locking Assay - Posaconazole - Product Status
        • Table Locking Assay - Posaconazole - Product Description
        • Table Phage-Based Assay - Product Status
        • Table Phage-Based Assay - Product Description
    • Animated Dynamics Inc Company Overview
      • Animated Dynamics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Animated Dynamics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table ONCO4D Assay - Product Status
        • Table ONCO4D Assay - Product Description
        • Table Animated Dynamics Inc - Ongoing Clinical Trials Overview
        • Table ONCO4D Assay - Feasibility Study of Motility Contrast Tomography for Predicting Therapeutic Response
        • Table ONCO4D Assay - Measuring the Impact of Onco4D Guidance
    • Applied Research using OMIC Sciences SL Company Overview
      • Applied Research using OMIC Sciences SL Pipeline Products & Ongoing Clinical Trials Overview
        • Table Applied Research using OMIC Sciences SL Pipeline Products & Ongoing Clinical Trials Overview
        • Table SNP-Test - Product Status
        • Table SNP-Test - Product Description
    • ARK Diagnostics Inc Company Overview
      • ARK Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table ARK Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table ARK Apixaban Assay - Product Status
        • Table ARK Apixaban Assay - Product Description
        • Table ARK Atazanavir Assay - Product Status
        • Table ARK Atazanavir Assay - Product Description
        • Table ARK Dabigatran Assay - Product Status
        • Table ARK Dabigatran Assay - Product Description
        • Table ARK Darunavir Assay - Product Status
        • Table ARK Darunavir Assay - Product Description
        • Table ARK Dolutegravir Assay - Product Status
        • Table ARK Dolutegravir Assay - Product Description
        • Table ARK Edoxaban Assay - Product Status
        • Table ARK Edoxaban Assay - Product Description
        • Table ARK High Sensitivity Opiates Assay - Product Status
        • Table ARK High Sensitivity Opiates Assay - Product Description
        • Table ARK Indinavir Assay - Product Status
        • Table ARK Indinavir Assay - Product Description
        • Table ARK Lopinavir Assay - Product Status
        • Table ARK Lopinavir Assay - Product Description
        • Table ARK Maraviroc Assay - Product Status
        • Table ARK Maraviroc Assay - Product Description
        • Table ARK Nelfinavir Assay - Product Status
        • Table ARK Nelfinavir Assay - Product Description
        • Table ARK Nevirapine Assay - Product Status
        • Table ARK Nevirapine Assay - Product Description
        • Table ARK Perampanel Assay - Product Status
        • Table ARK Perampanel Assay - Product Description
        • Table ARK Rivaroxaban Assay - Product Status
        • Table ARK Rivaroxaban Assay - Product Description
        • Table ARK Saquinavir Assay - Product Status
        • Table ARK Saquinavir Assay - Product Description
        • Table ARK Tiagabine Assay - Product Status
        • Table ARK Tiagabine Assay - Product Description
        • Table ARK Zolpidem Assay - Product Status
        • Table ARK Zolpidem Assay - Product Description
        • Table ARK Zopiclone Assay - Product Status
        • Table ARK Zopiclone Assay - Product Description
    • AutoGenomics Inc Company Overview
      • AutoGenomics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table AutoGenomics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Plavix Panel Test - Product Status
        • Table Plavix Panel Test - Product Description
    • Avacta Group Plc Company Overview
      • Avacta Group Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Avacta Group Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Depression Test - Product Status
        • Table Depression Test - Product Description
        • Table Diagnostic Assay - Alzheimer's Disease - Product Status
        • Table Diagnostic Assay - Alzheimer's Disease - Product Description
        • Table Diagnostic Test - ADHD - Product Status
        • Table Diagnostic Test - ADHD - Product Description
        • Table Diagnostic Test - Bipolar Disorder - Product Status
        • Table Diagnostic Test - Bipolar Disorder - Product Description
        • Table Schizophrenia Response Test - Product Status
        • Table Schizophrenia Response Test - Product Description
        • Table Schizophrenia Side Effects Test - Product Status
        • Table Schizophrenia Side Effects Test - Product Description
    • BG Medicine Inc Company Overview
      • BG Medicine Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table BG Medicine Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Avandia Response - Product Status
        • Table Avandia Response - Product Description
        • Table Biomarker Test - Enbrel - Product Status
        • Table Biomarker Test - Enbrel - Product Description
        • Table Biomarker Test - Humira - Product Status
        • Table Biomarker Test - Humira - Product Description
        • Table Biomarker Test - Remicade - Product Status
        • Table Biomarker Test - Remicade - Product Description
    • BIOHOPE Scientific SL Company Overview
      • BIOHOPE Scientific SL Pipeline Products & Ongoing Clinical Trials Overview
        • Table BIOHOPE Scientific SL Pipeline Products & Ongoing Clinical Trials Overview
        • Table Immunobiogram - Renal Transplantation - Product Status
        • Table Immunobiogram - Renal Transplantation - Product Description
        • Table BIOHOPE Scientific SL - Ongoing Clinical Trials Overview
        • Table Immunobiogram - Renal Transplantation - Longitudinal Observational Study to Determine the Correlation Between Patient's Pharmacodynamic Response to Immunosuppressants Measured in Vitro with IMMUNOBIOGRAM and of Rejection in Graft Biopsies in Patients with Renal Transplantation
    • Boston University Company Overview
      • Boston University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Boston University Pipeline Products & Ongoing Clinical Trials Overview
        • Table ELISA Assay - Tenofovir - Product Status
        • Table ELISA Assay - Tenofovir - Product Description
    • CCC Diagnostics LLC Company Overview
      • CCC Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table CCC Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table DirectHit Drug Response Indicator Test Panel - Gastrointestinal Cancer - Product Status
        • Table DirectHit Drug Response Indicator Test Panel - Gastrointestinal Cancer - Product Description
    • Centre Hospitalier Universitaire de Nice Company Overview
      • Centre Hospitalier Universitaire de Nice Pipeline Products & Ongoing Clinical Trials Overview
        • Table Centre Hospitalier Universitaire de Nice Pipeline Products & Ongoing Clinical Trials Overview
        • Table Azacitidine Resistance Assay - Product Status
        • Table Azacitidine Resistance Assay - Product Description
    • Chronix Biomedical Inc Company Overview
      • Chronix Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Chronix Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Therapeutic Monitoring Test - Pancreatic Cancer - Product Status
        • Table Therapeutic Monitoring Test - Pancreatic Cancer - Product Description
    • Cognizance Biomarkers LLC Company Overview
      • Cognizance Biomarkers LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cognizance Biomarkers LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Blood Assay - mTOR Signaling - Product Status
        • Table Blood Assay - mTOR Signaling - Product Description
    • Columbia University Company Overview
      • Columbia University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Columbia University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diagnostic Assay - Acetylcholinesterase (AChE) Activity - Product Status
        • Table Diagnostic Assay - Acetylcholinesterase (AChE) Activity - Product Description
    • ContraVac Inc (Inactive) Company Overview
      • ContraVac Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table ContraVac Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table SpermCheck - Contraception - Product Status
        • Table SpermCheck - Contraception - Product Description
    • Denovo Biolabs Pvt Ltd Company Overview
      • Denovo Biolabs Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Denovo Biolabs Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table DeQuanto Trastuzumab (Herceptin) PK ELISA KIT - Product Status
        • Table DeQuanto Trastuzumab (Herceptin) PK ELISA KIT - Product Description
    • DNAPrint Genomics Inc (Inactive) Company Overview
      • DNAPrint Genomics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table DNAPrint Genomics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Acenome - Product Status
        • Table Acenome - Product Description
        • Table Melphalan/Topotecan Response Test - Product Status
        • Table Melphalan/Topotecan Response Test - Product Description
        • Table Statinome - Product Status
        • Table Statinome - Product Description
    • Dublin City University Company Overview
      • Dublin City University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Dublin City University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biomarker Based Test - Multiple Myeloma - Product Status
        • Table Biomarker Based Test - Multiple Myeloma - Product Description
    • Ecole Polytechnique Federale de Lausanne Company Overview
      • Ecole Polytechnique Federale de Lausanne Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ecole Polytechnique Federale de Lausanne Pipeline Products & Ongoing Clinical Trials Overview
        • Table Portable Biosensor - Product Status
        • Table Portable Biosensor - Product Description
    • ELITechGroup Inc Company Overview
      • ELITechGroup Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table ELITechGroup Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Eon 300 Automated Chemistry Analyzer - TxB Cardio Assay - Product Status
        • Table Eon 300 Automated Chemistry Analyzer - TxB Cardio Assay - Product Description
        • Table Eon Digoxin Assay - Product Status
        • Table Eon Digoxin Assay - Product Description
        • Table Eon Theophylline Assay - Product Status
        • Table Eon Theophylline Assay - Product Description
        • Table Phenobarbital Assay - Product Status
        • Table Phenobarbital Assay - Product Description
        • Table Phenytoin Assay - Product Status
        • Table Phenytoin Assay - Product Description
        • Table Selectra ProM Chemistry System - TxB Cardio Assay - Product Status
        • Table Selectra ProM Chemistry System - TxB Cardio Assay - Product Description
        • Table Selectra ProS Chemistry System - TxB Cardio Assay - Product Status
        • Table Selectra ProS Chemistry System - TxB Cardio Assay - Product Description
    • Eurobio Scientific SA Company Overview
      • Eurobio Scientific SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table Eurobio Scientific SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table Therapeutic Drug Monitoring Test - Resistant Cancer - Product Status
        • Table Therapeutic Drug Monitoring Test - Resistant Cancer - Product Description
    • Gene Express, Inc. (Inactive) Company Overview
      • Gene Express, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Gene Express, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cisplatin Chemoresistance Test - Product Status
        • Table Cisplatin Chemoresistance Test - Product Description
        • Table Prognostic Test - Irinotecan Chemoresistance - Product Status
        • Table Prognostic Test - Irinotecan Chemoresistance - Product Description
    • GenMark Diagnostics Inc Company Overview
      • GenMark Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table GenMark Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table 2D6 Tamoxifen Metabolism Test - Product Status
        • Table 2D6 Tamoxifen Metabolism Test - Product Description
        • Table eSensor 2C19 Genotyping Test - Product Status
        • Table eSensor 2C19 Genotyping Test - Product Description
    • Horiba Ltd Company Overview
      • Horiba Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Horiba Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table ABX Pentra 400 Analyzer - TDM Assay - Product Status
        • Table ABX Pentra 400 Analyzer - TDM Assay - Product Description
        • Table Pentra C200 Analyzer - TDM Assay - Product Status
        • Table Pentra C200 Analyzer - TDM Assay - Product Description
    • Inflammatix Inc Company Overview
      • Inflammatix Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Inflammatix Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table HostDxTNFresponse - Product Status
        • Table HostDxTNFresponse - Product Description
    • Instrumentation Laboratory Co Company Overview
      • Instrumentation Laboratory Co Pipeline Products & Ongoing Clinical Trials Overview
        • Table Instrumentation Laboratory Co Pipeline Products & Ongoing Clinical Trials Overview
        • Table HemosIL Dabigatran Assay - Product Status
        • Table HemosIL Dabigatran Assay - Product Description
    • Johns Hopkins University Company Overview
      • Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Predictive Test For Chemotherapy Regimen - Product Status
        • Table Predictive Test For Chemotherapy Regimen - Product Description
    • KIYATEC Inc Company Overview
      • KIYATEC Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table KIYATEC Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ex Vivo 3D Drug Response (EV3D) Assay - Product Status
        • Table Ex Vivo 3D Drug Response (EV3D) Assay - Product Description
        • Table KIYATEC Inc - Ongoing Clinical Trials Overview
        • Table Ex Vivo 3D Drug Response (EV3D) Assay - 3D Prediction of Patient-specific Response Using Ex Vivo Interrogation of Live Cells from Tumors: 3D-PREDICT REGISTRY
    • Medibio Ltd Company Overview
      • Medibio Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Medibio Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Medibio RX - Bipolar - Product Status
        • Table Medibio RX - Bipolar - Product Description
        • Table Medibio RX - General Anxiety Disorders - Product Status
        • Table Medibio RX - General Anxiety Disorders - Product Description
        • Table Medibio RX - PTSD - Product Status
        • Table Medibio RX - PTSD - Product Description
        • Table Medibio RX - Schizophrenia - Product Status
        • Table Medibio RX - Schizophrenia - Product Description
    • Medical Research Council Company Overview
      • Medical Research Council Pipeline Products & Ongoing Clinical Trials Overview
        • Table Medical Research Council Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diagnostic Assay - Hormone Dependent Tumours - Product Status
        • Table Diagnostic Assay - Hormone Dependent Tumours - Product Description
    • Metabolon Inc Company Overview
      • Metabolon Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Metabolon Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cisplatin Tolerance Test - Product Status
        • Table Cisplatin Tolerance Test - Product Description
        • Table Prostate Cancer TDM Test - Product Status
        • Table Prostate Cancer TDM Test - Product Description
    • Newcastle University Company Overview
      • Newcastle University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Newcastle University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Thiopurines Assay - Product Status
        • Table Thiopurines Assay - Product Description
    • Nipro Europe N.V. Company Overview
      • Nipro Europe N.V. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nipro Europe N.V. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Lithium Assay - Product Status
        • Table Lithium Assay - Product Description
    • Nuclea Biotechnologies Inc. (Inactive) Company Overview
      • Nuclea Biotechnologies Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nuclea Biotechnologies Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table EGFR TK Sensitivity Lung Cancer Diagnostic Test - Product Status
        • Table EGFR TK Sensitivity Lung Cancer Diagnostic Test - Product Description
        • Table Irinotecan Sensitivity Diagnostic Test - Colon Cancer - Product Status
        • Table Irinotecan Sensitivity Diagnostic Test - Colon Cancer - Product Description
    • PanGenomic Health Inc Company Overview
      • PanGenomic Health Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table PanGenomic Health Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Treatment Efficacy Monitoring Assay - Product Status
        • Table Treatment Efficacy Monitoring Assay - Product Description
    • Pax Neuroscience Inc Company Overview
      • Pax Neuroscience Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Pax Neuroscience Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table MoodMark Rx - Product Status
        • Table MoodMark Rx - Product Description
    • Pelago Bioscience AB Company Overview
      • Pelago Bioscience AB Pipeline Products & Ongoing Clinical Trials Overview
        • Table Pelago Bioscience AB Pipeline Products & Ongoing Clinical Trials Overview
        • Table CETSA - Product Status
        • Table CETSA - Product Description
    • Pennsylvania State University Company Overview
      • Pennsylvania State University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Pennsylvania State University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Antiobody-Based ELISA Assay - ACTS - Product Status
        • Table Antiobody-Based ELISA Assay - ACTS - Product Description
    • Plateletdiagnostics LLC Company Overview
      • Plateletdiagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Plateletdiagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table pDrp1 Assay - Product Status
        • Table pDrp1 Assay - Product Description
    • Prediction Sciences LLC (Inactive) Company Overview
      • Prediction Sciences LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Prediction Sciences LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table GeneRx For Hypertension Treatment - Product Status
        • Table GeneRx For Hypertension Treatment - Product Description
        • Table GeneRx Lithium/Bipolar Test - Product Status
        • Table GeneRx Lithium/Bipolar Test - Product Description
    • ProciseDx LLC Company Overview
      • ProciseDx LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table ProciseDx LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Procise ADL - Product Status
        • Table Procise ADL - Product Description
        • Table Procise IFX - Product Status
        • Table Procise IFX - Product Description
    • Progenika Biopharma SA Company Overview
      • Progenika Biopharma SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table Progenika Biopharma SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table Promonitor - Autoimmune And Inflammation - Product Status
        • Table Promonitor - Autoimmune And Inflammation - Product Description
    • PrognosDx Health Inc Company Overview
      • PrognosDx Health Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table PrognosDx Health Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table RxScore Therapeutic Response Test - Breast Cancer - Product Status
        • Table RxScore Therapeutic Response Test - Breast Cancer - Product Description
        • Table RxScore Therapeutic Response Test - Pancreatic Cancer - Product Status
        • Table RxScore Therapeutic Response Test - Pancreatic Cancer - Product Description
    • Prometheus Laboratories Inc Company Overview
      • Prometheus Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Prometheus Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table PL-200 PredictrPK - CD/UC Adalimumab - Product Status
        • Table PL-200 PredictrPK - CD/UC Adalimumab - Product Description
        • Table PL-200 PredictrPK - CD/UC Infliximab - Product Status
        • Table PL-200 PredictrPK - CD/UC Infliximab - Product Description
        • Table PL-200 PredictrPK - CD/UC Ustekinumab - Product Status
        • Table PL-200 PredictrPK - CD/UC Ustekinumab - Product Description
        • Table PL-200 PredictrPK - CD/UC Vedolizumab - Product Status
        • Table PL-200 PredictrPK - CD/UC Vedolizumab - Product Description
        • Table PL-300 Monitr - Product Status
        • Table PL-300 Monitr - Product Description
        • Table PL-400 CD/UC Infliximab/Adalimumab - Product Status
        • Table PL-400 CD/UC Infliximab/Adalimumab - Product Description
        • Table PL-600 Anser CD Risankizumab - Product Status
        • Table PL-600 Anser CD Risankizumab - Product Description
    • Proteomika (Inactive) Company Overview
      • Proteomika (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Proteomika (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Promonitor-Anti-CZP (Certolizumab) - Product Status
        • Table Promonitor-Anti-CZP (Certolizumab) - Product Description
        • Table Promonitor-Anti-TCZ (Tocilizumab) - Product Status
        • Table Promonitor-Anti-TCZ (Tocilizumab) - Product Description
        • Table Promonitor-CZP (Certolizumab) - Product Status
        • Table Promonitor-CZP (Certolizumab) - Product Description
        • Table Promonitor-TCZ (Tocilizumab) - Product Status
        • Table Promonitor-TCZ (Tocilizumab) - Product Description
    • Purdue University Company Overview
      • Purdue University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Purdue University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Point-Of-Care Mass Spectrometry Analysis System - Product Status
        • Table Point-Of-Care Mass Spectrometry Analysis System - Product Description
    • Queen Mary University of London Company Overview
      • Queen Mary University of London Pipeline Products & Ongoing Clinical Trials Overview
        • Table Queen Mary University of London Pipeline Products & Ongoing Clinical Trials Overview
        • Table Hepatocyte - Based Drug Screen Assay - Product Status
        • Table Hepatocyte - Based Drug Screen Assay - Product Description
    • Roche Diagnostics Corp Company Overview
      • Roche Diagnostics Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Roche Diagnostics Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Liat Assay - Pharmacogenomics - Product Status
        • Table Liat Assay - Pharmacogenomics - Product Description
    • Roche Diagnostics International Ltd Company Overview
      • Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cobas - Cyclosporin A Assay - Product Status
        • Table Cobas - Cyclosporin A Assay - Product Description
        • Table Cobas 6000 Analyzer Series With c 501 Module - Cyclosporine Assay - Product Status
        • Table Cobas 6000 Analyzer Series With c 501 Module - Cyclosporine Assay - Product Description
        • Table Cobas 6000 Analyzer Series With c 501 Module - Lidocaine Assay - Product Status
        • Table Cobas 6000 Analyzer Series With c 501 Module - Lidocaine Assay - Product Description
        • Table Cobas 6000 Analyzer Series With c 501 Module - Tacrolimus Assay - Product Status
        • Table Cobas 6000 Analyzer Series With c 501 Module - Tacrolimus Assay - Product Description
        • Table Cobas 6000 Analyzer Series With e 601 Module - Cyclosporine Assay - Product Status
        • Table Cobas 6000 Analyzer Series With e 601 Module - Cyclosporine Assay - Product Description
        • Table Cobas 6000 Analyzer Series With e 601 Module - Everolimus Assay - Product Status
        • Table Cobas 6000 Analyzer Series With e 601 Module - Everolimus Assay - Product Description
        • Table Cobas 6000 Analyzer Series With e 601 Module - Sirolimus Assay - Product Status
        • Table Cobas 6000 Analyzer Series With e 601 Module - Sirolimus Assay - Product Description
        • Table Cobas 8000 Analyzer Series With c 502 Module - Everolimus Assay - Product Status
        • Table Cobas 8000 Analyzer Series With c 502 Module - Everolimus Assay - Product Description
        • Table Cobas 8000 Analyzer Series With c 502 Module - Lidocaine Assay - Product Status
        • Table Cobas 8000 Analyzer Series With c 502 Module - Lidocaine Assay - Product Description
        • Table Cobas 8000 Analyzer Series With c 502 Module - Sirolimus Assay - Product Status
        • Table Cobas 8000 Analyzer Series With c 502 Module - Sirolimus Assay - Product Description
        • Table Cobas 8000 Analyzer Series With c 502 Module - Tacrolimus Assay - Product Status
        • Table Cobas 8000 Analyzer Series With c 502 Module - Tacrolimus Assay - Product Description
        • Table Cobas 8000 Analyzer Series With c 701 Module - Everolimus Assay - Product Status
        • Table Cobas 8000 Analyzer Series With c 701 Module - Everolimus Assay - Product Description
        • Table Cobas 8000 Analyzer Series With c 701 Module - Lidocaine Assay - Product Status
        • Table Cobas 8000 Analyzer Series With c 701 Module - Lidocaine Assay - Product Description
        • Table Cobas 8000 Analyzer Series With c 701 Module - Sirolimus Assay - Product Status
        • Table Cobas 8000 Analyzer Series With c 701 Module - Sirolimus Assay - Product Description
        • Table Cobas 8000 Analyzer Series With c 701 Module - Tacrolimus Assay - Product Status
        • Table Cobas 8000 Analyzer Series With c 701 Module - Tacrolimus Assay - Product Description
        • Table Cobas 8000 Analyzer Series With c 702 Module - Everolimus Assay - Product Status
        • Table Cobas 8000 Analyzer Series With c 702 Module - Everolimus Assay - Product Description
        • Table Cobas 8000 Analyzer Series With c 702 Module - Lidocaine Assay - Product Status
        • Table Cobas 8000 Analyzer Series With c 702 Module - Lidocaine Assay - Product Description
        • Table Cobas 8000 Analyzer Series With c 702 Module - Sirolimus Assay - Product Status
        • Table Cobas 8000 Analyzer Series With c 702 Module - Sirolimus Assay - Product Description
        • Table Cobas 8000 Analyzer Series With c 702 Module - Tacrolimus Assay - Product Status
        • Table Cobas 8000 Analyzer Series With c 702 Module - Tacrolimus Assay - Product Description
        • Table Cobas 8000 Analyzer Series With e 602 Module - Everolimus Assay - Product Status
        • Table Cobas 8000 Analyzer Series With e 602 Module - Everolimus Assay - Product Description
        • Table Cobas 8000 Analyzer Series With e 602 Module - Lidocaine Assay - Product Status
        • Table Cobas 8000 Analyzer Series With e 602 Module - Lidocaine Assay - Product Description
        • Table Cobas 8000 Analyzer Series With e 801 Module - Everolimus Assay - Product Status
        • Table Cobas 8000 Analyzer Series With e 801 Module - Everolimus Assay - Product Description
        • Table Cobas 8000 Analyzer Series With e 801 Module - Tacrolimus Assay - Product Status
        • Table Cobas 8000 Analyzer Series With e 801 Module - Tacrolimus Assay - Product Description
        • Table Cobas t 511 Coagulation Analyzer - Apixaban Assay - Product Status
        • Table Cobas t 511 Coagulation Analyzer - Apixaban Assay - Product Description
        • Table Cobas t 511 Coagulation Analyzer - Dabigatran Assay - Product Status
        • Table Cobas t 511 Coagulation Analyzer - Dabigatran Assay - Product Description
        • Table Cobas t 511 Coagulation Analyzer - Rivaroxaban Assay - Product Status
        • Table Cobas t 511 Coagulation Analyzer - Rivaroxaban Assay - Product Description
        • Table Cobas t 711 Coagulation Analyzer - Apixaban Assay - Product Status
        • Table Cobas t 711 Coagulation Analyzer - Apixaban Assay - Product Description
        • Table Cobas t 711 Coagulation Analyzer - Dabigatran Assay - Product Status
        • Table Cobas t 711 Coagulation Analyzer - Dabigatran Assay - Product Description
        • Table Cobas t 711 Coagulation Analyzer - Rivaroxaban Assay - Product Status
        • Table Cobas t 711 Coagulation Analyzer - Rivaroxaban Assay - Product Description
        • Table Integrated Modular Analytics - Tacrolimus Test - Product Status
        • Table Integrated Modular Analytics - Tacrolimus Test - Product Description
        • Table Integrated Modular Analytics System - Mycophenolic Acid Test - Product Status
        • Table Integrated Modular Analytics System - Mycophenolic Acid Test - Product Description
    • Rockland Immunochemicals Inc Company Overview
      • Rockland Immunochemicals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Rockland Immunochemicals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Akt/mTOR Signaling Pharmacodynamics Assay - Product Status
        • Table Akt/mTOR Signaling Pharmacodynamics Assay - Product Description
    • SAGA Diagnostics AB Company Overview
      • SAGA Diagnostics AB Pipeline Products & Ongoing Clinical Trials Overview
        • Table SAGA Diagnostics AB Pipeline Products & Ongoing Clinical Trials Overview
        • Table IBSAFE - Therapy Response Monitoring & Drug Resistance - Product Status
        • Table IBSAFE - Therapy Response Monitoring & Drug Resistance - Product Description
        • Table KROMA - Therapy Response Monitoring & Drug Resistance - Product Status
        • Table KROMA - Therapy Response Monitoring & Drug Resistance - Product Description
    • Saladax Biomedical Inc Company Overview
      • Saladax Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Saladax Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table MyCare Assay - Busulfan - Product Status
        • Table MyCare Assay - Busulfan - Product Description
        • Table MyCare Assay - Cyclophosphamide - Product Status
        • Table MyCare Assay - Cyclophosphamide - Product Description
        • Table MyCare Assay - Doxorubicin - Product Status
        • Table MyCare Assay - Doxorubicin - Product Description
        • Table MyCare Assay - Gemcitabine - Product Status
        • Table MyCare Assay - Gemcitabine - Product Description
        • Table MyCare Assay - Irinotecan - Product Status
        • Table MyCare Assay - Irinotecan - Product Description
        • Table MyCare Assay - Lenalidomide - Product Status
        • Table MyCare Assay - Lenalidomide - Product Description
        • Table MyCare Assay - Thalidomide - Product Status
        • Table MyCare Assay - Thalidomide - Product Description
        • Table MyCare Assay - Tyrosine Kinase Inhibitor - Product Status
        • Table MyCare Assay - Tyrosine Kinase Inhibitor - Product Description
        • Table MyCare Assay - Vincristine - Product Status
        • Table MyCare Assay - Vincristine - Product Description
        • Table MyCare Psychiatry Aripiprazole Assay Kit - Product Status
        • Table MyCare Psychiatry Aripiprazole Assay Kit - Product Description
        • Table MyCare Psychiatry Olanzapine Assay Kit - Product Status
        • Table MyCare Psychiatry Olanzapine Assay Kit - Product Description
        • Table MyCare Psychiatry Quetiapine Assay Kit - Product Status
        • Table MyCare Psychiatry Quetiapine Assay Kit - Product Description
        • Table MyCare Psychiatry Total Risperidone Assay Kit - Product Status
        • Table MyCare Psychiatry Total Risperidone Assay Kit - Product Description
        • Table Nanoparticle Immunoassay Kit - TDM - Product Status
        • Table Nanoparticle Immunoassay Kit - TDM - Product Description
        • Table Saladax Biomedical Inc - Ongoing Clinical Trials Overview
        • Table MyCare Assay - Busulfan - Collection of Plasma Samples Using Sodium Heparin From Subjects Undergoing Intravenous Busulfan Treatment
    • Siemens Healthcare Diagnostics Inc Company Overview
      • Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table ADVIA Everolimus Assay - Product Status
        • Table ADVIA Everolimus Assay - Product Description
        • Table ADVIA Sirolimus Assay - Product Status
        • Table ADVIA Sirolimus Assay - Product Description
        • Table ADVIA Tacrolimus Assay - Product Status
        • Table ADVIA Tacrolimus Assay - Product Description
        • Table Atellica IM Analyzer - Everolimus Assay - Product Status
        • Table Atellica IM Analyzer - Everolimus Assay - Product Description
        • Table Atellica IM Analyzer - Sirolimus Assay - Product Status
        • Table Atellica IM Analyzer - Sirolimus Assay - Product Description
        • Table Atellica Solution Clinical Chemistry Analyzer - Levetiracetam - Product Status
        • Table Atellica Solution Clinical Chemistry Analyzer - Levetiracetam - Product Description
    • Sirius Genomics Inc Company Overview
      • Sirius Genomics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Sirius Genomics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Pharmacogenetic Test - Product Status
        • Table Pharmacogenetic Test - Product Description
    • Spanish National Research Council Company Overview
      • Spanish National Research Council Pipeline Products & Ongoing Clinical Trials Overview
        • Table Spanish National Research Council Pipeline Products & Ongoing Clinical Trials Overview
        • Table Blood-Based Immunoassay - Oral Anticoagulants - Product Status
        • Table Blood-Based Immunoassay - Oral Anticoagulants - Product Description
    • SQI Diagnostics Inc Company Overview
      • SQI Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table SQI Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ig_PLEX TNF Assay - Product Status
        • Table Ig_PLEX TNF Assay - Product Description
        • Table Multiplex Anti Drug Antibody Assay - Product Status
        • Table Multiplex Anti Drug Antibody Assay - Product Description
    • T2 Biosystems Inc Company Overview
      • T2 Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table T2 Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table T2Endotoxin - Product Status
        • Table T2Endotoxin - Product Description
    • Thermo Fisher Scientific Inc Company Overview
      • Thermo Fisher Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Thermo Fisher Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cascadion SM Clinical Analyzer - Therapeutic Drug Monitoring - Product Status
        • Table Cascadion SM Clinical Analyzer - Therapeutic Drug Monitoring - Product Description
        • Table Cascadion SM Immunosuppressants Panel - Product Status
        • Table Cascadion SM Immunosuppressants Panel - Product Description
    • Universidade Feevale Company Overview
      • Universidade Feevale Pipeline Products & Ongoing Clinical Trials Overview
        • Table Universidade Feevale Pipeline Products & Ongoing Clinical Trials Overview
        • Table Dried Plasma Spot Assay - Therapeutic Drug Monitoring - Product Status
        • Table Dried Plasma Spot Assay - Therapeutic Drug Monitoring - Product Description
    • University of Colorado Company Overview
      • University of Colorado Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Colorado Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biomarker Assay - Schizophrenia - Product Status
        • Table Biomarker Assay - Schizophrenia - Product Description
        • Table Pharmacokinetic Drug Monitoring Device - Product Status
        • Table Pharmacokinetic Drug Monitoring Device - Product Description
    • University of Colorado Denver Company Overview
      • University of Colorado Denver Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Colorado Denver Pipeline Products & Ongoing Clinical Trials Overview
        • Table Therapeutic Drug Monitoring Test - HIV - Product Status
        • Table Therapeutic Drug Monitoring Test - HIV - Product Description
    • University of North Dakota Company Overview
      • University of North Dakota Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of North Dakota Pipeline Products & Ongoing Clinical Trials Overview
        • Table Screening Assay - Anti Viral Drug - Product Status
        • Table Screening Assay - Anti Viral Drug - Product Description
    • University of Queensland Company Overview
      • University of Queensland Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Queensland Pipeline Products & Ongoing Clinical Trials Overview
        • Table Theranostic Assay - Squamous Cell Carcinoma - Product Status
        • Table Theranostic Assay - Squamous Cell Carcinoma - Product Description
    • University of Washington Company Overview
      • University of Washington Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Washington Pipeline Products & Ongoing Clinical Trials Overview
        • Table Point-Of-Care Assay - Tenofovir - Product Status
        • Table Point-Of-Care Assay - Tenofovir - Product Description
    • Vyant Bio Inc Company Overview
      • Vyant Bio Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Vyant Bio Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Comprehensive Pharmacogenomics Panel Test - Product Status
        • Table Comprehensive Pharmacogenomics Panel Test - Product Description
  • Therapeutic Drug Monitoring- Recent Developments
    • Jul 17, 2023: Theradiag Reports Revenue of 6.7 Million for the First Half of 2023, up 6.8%
    • Jul 12, 2023: T2 Biosystems Announces Preliminary Second Quarter 2023 Financial Results
    • Jul 12, 2023: Revvity to Hold Earnings Call on Tuesday, August 1, 2023
    • Jul 05, 2023: Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, July 26, 2023
    • Jul 05, 2023: Waters Corp. Schedules Second Quarter 2023 Earnings Conference Call
    • Jun 12, 2023: Abbott Names Philip Boudreau CFO effective Sept. 1
    • Jun 02, 2023: Avacta Group Posting of Annual Report and Notice of AGM
    • May 30, 2023: SQI Diagnostics reports second quarter 2023 results
    • May 16, 2023: Genflow Biosciences Notice of Annual General Meeting
    • May 15, 2023: T2 Biosystems postpones reporting of first quarter 2023 financial results
    • May 12, 2023: Acurx Pharmaceuticals reports first quarter 2023 results and provides business update
    • May 12, 2023: Olympus announces consolidated financial results for the fiscal year ended March 31, 2023
    • May 12, 2023: Horiba announces summary of consolidated financial statements for the three months ended March 31, 2023
    • May 11, 2023: Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2023
    • May 11, 2023: Nusano announces in-house stable isotope program led by renowned physicist Sarko Cherekdjian
    • May 09, 2023: Natera reports first quarter 2023 financial results
    • May 05, 2023: Acurx Pharmaceuticals to discuss first quarter 2023 financial results and provide business update
    • May 04, 2023: Nusano to Host Key Opinion Leader Webinar on Isotope Production and Applications for Oncology Radiopharmaceuticals
    • May 03, 2023: Adaptive Biotechnologies reports First Quarter 2023 financial results
    • Apr 17, 2023: Nusano announces Q1 2025 opening date for medical radioisotope production facility in Utah
    • Apr 05, 2023: Eurobio Scientific Announces 2022 Annual Results
    • Apr 03, 2023: Avacta Group Announces Notice of Financial Results for 31 December 2022
    • Mar 31, 2023: HealthBeacon Announces 2022 Preliminary Results
    • Mar 22, 2023: DiagnaMed Announces Dr. Bassma Ghali as Vice President of Product
    • Mar 16, 2023: Acurx Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Results and Provides Business Update
    • Mar 16, 2023: Incannex to Commercialise its Psychedelic Clinics Business in Collaborative Partnership with Leading Psychedelic Experts
    • Mar 15, 2023: Clario Announces Global Clinical Research Expert, Rod MacKenzie CMG, PH.D., New Chairman of the Board of Directors
    • Mar 13, 2023: T2 Biosystems Announces Fourth Quarter and Full Year 2022 Financial Results
    • Mar 09, 2023: Summit Therapeutics Reports Financial Results and Operational Progress for the Fourth Quarter and Year Ended December 31, 2022
    • Mar 09, 2023: PerkinElmer to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
    • Feb 24, 2023: Diagnostix elects Ger van Jeveren to its board of directors ahead of IPO
    • Feb 23, 2023: Natera Appoints Ruth E. Williams-Brinkley to its Board of Directors
    • Feb 21, 2023: Halberd demonstrates simultaneous eradication of multiple strains of CDC provided antibiotic resistant bacteria
    • Feb 15, 2023: Mahana Therapeutics Appoints Justin Zamirowski, Jr. as Chief Commercial Officer
    • Feb 14, 2023: Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2022 Financial Results
    • Feb 14, 2023: Horiba Announces Summary of Consolidated Financial Statements for the Year Ended December 31, 2022
    • Feb 13, 2023: DiagnaMed Announces Appointment of New Director
    • Feb 10, 2023: Olympus Announces Consolidated Financial Results for the Third Quarter and Full-year Forecasts for Fiscal 2023
    • Feb 09, 2023: SenzaGen Invitation to the presentation of year-end report 2022 on Feb 16 at 14.00 CET
    • Feb 09, 2023: Oxford scientists develop test that can identify respiratory viruses within five minutes
    • Feb 08, 2023: Eurobio Scientific formalises the appointment of Anne-Sophie Herelle as Group CFO
    • Feb 07, 2023: Unchained Labs goes viral again with new adenovirus quant application on stunner
    • Feb 07, 2023: BioMark receives funding, support, research and development project for cancer treatment monitoring
    • Feb 01, 2023: Cairn Homes Announces Ms. Orla O'Gorman step down as Non-Executive Director of HealthBeacon
    • Jan 23, 2023: Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2022 Financial Results on February 14, 2023
    • Jan 23, 2023: T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2022 Financial Results
    • Jan 20, 2023: Quest Diagnostics to Release Fourth Quarter and Full Year 2022 Financial Results on February 2, 2023
    • Jan 20, 2023: Joint statement by Executive Steering Group on shortages and safety of medicinal products (MSSG) on shortages of antibiotic medicines
    • Jan 18, 2023: Waters Corporation Schedules Fourth Quarter 2022 Earnings Conference Call
    • Jan 16, 2023: TheraDiag Reports 2022 Revenue of 12.2 Million, up 9.7%
    • Jan 08, 2023: Hologic Announces Preliminary Revenue Results for First Quarter of Fiscal 2023
    • Dec 23, 2022: Asep Medical achieves significant milestones addressing antibiotic failure through proprietary diagnostic & therapeutic technologies
    • Dec 20, 2022: New blood test to identify infections could reduce global antibiotic overuse
    • Dec 16, 2022: HealthBeacon appoints Lar Malone as interim chief financial officer
    • Dec 15, 2022: Bristol Myers Squibb to Report Results for Fourth Quarter 2022 on February 2, 2023
    • Nov 21, 2022: Thermo Fisher Scientific to Present at Evercore ISI HealthCONx Conference
    • Nov 11, 2022: Olympus Consolidated Financial Results for the Six Months of the Fiscal Year Ending March 31, 2023
    • Nov 11, 2022: Horiba Announces Summary of Consolidated Financial Statements for the Nine Months Ended September 30, 2022
    • Nov 11, 2022: Olympus Announces Consolidated Financial Results for the Six Months of the Fiscal Year Ending March 31, 2023
    • Nov 09, 2022: Summit Therapeutics Reports Financial Results and Operational Progress for the Third Quarter and Nine Months Ended September 30, 2022
    • Nov 08, 2022: PerkinElmer Announces Financial Results for the Third Quarter of 2022
    • Nov 03, 2022: Adaptive Biotechnologies Reports Third Quarter 2022 Financial Results
    • Nov 01, 2022: Waters Corp Reports Third Quarter 2022 Financial Results
    • Oct 24, 2022: Cohere Health and Humana Expand Partnership to Further Improve Physician and Member Experiences
    • Oct 21, 2022: Olympus Announces Leadership Succession Plan
    • Oct 21, 2022: Olympus Corp Notice Concerning Changes of Representative Executive Officer and Management Team
    • Oct 13, 2022: Biomerica Reports 30% Increase in Revenues for Fiscal Q1 2023 vs. Fiscal Q1 2022
    • Oct 12, 2022: T2 Biosystems Announces Preliminary Third Quarter 2022 Financial Results and Updates 2022 Financial Outlook
    • Oct 10, 2022: Creso Pharma accelerates company strategy with two new Director appointments, board transition and rebranding strategy to unlock additional M&A opportunities
    • Sep 30, 2022: Theradiag: Appointment of an Independent Expert
    • Sep 29, 2022: Avacta Group Announces Interim Results for the Period Ended 30 June 2022
    • Sep 19, 2022: Theradiag Announces Its Results for the First Half of 2022: Breaking-Even and Confirming Its Ability to Be Structurally Profitable From Early 2023
    • Sep 14, 2022: Horiba announces Review of First Half of 2022
    • Sep 08, 2022: Quest Diagnostics to Speak at the Morgan Stanley 20th Annual Global Healthcare Conference
    • Sep 07, 2022: Amneal Appoints Gustavo Pesquin as Executive Vice President Chief Commercial Officer
    • Aug 31, 2022: Bristol Myers Squibb to Participate in Citi's 17th Annual BioPharma Conference
    • Aug 30, 2022: Biomerica Plans Launch of InFoods IBS Test; Names Robert Carlson as Chief Commercial Officer
    • Aug 29, 2022: SQI Diagnostics Reports Third Quarter 2022 Results
    • Aug 24, 2022: New line of electrochemistry bench meters simplify pH, conductivity and dissolved oxygen measurement
    • Aug 15, 2022: Acurx Pharmaceuticals Reports Second Quarter 2022 Results
    • Aug 12, 2022: Horiba announce Summary of Consolidated Financial Statements for the Six Months Ended June 30, 2022
    • Aug 11, 2022: Summit Therapeutics Reports Financial Results and Operational Progress for the Second Quarter Ended June 30, 2022
    • Aug 11, 2022: Precipio Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
    • Aug 10, 2022: Olympus announces First Quarter Results
    • Aug 09, 2022: Olympus Corp. Announces Consolidated Financial Results for the Three Months of the Fiscal Year Ending March 31, 2023
    • Aug 08, 2022: Precipio Announces Second Quarter Shareholder Update Call
    • Aug 04, 2022: Aurinia Reports Second Quarter and Six Months 2022 Financial and Operational Results
    • Aug 03, 2022: Adaptive Biotechnologies Reports Second Quarter 2022 Financial Results
    • Aug 01, 2022: PerkinElmer Announces Financial Results for the Second Quarter of 2022
  • Appendix
    • Methodology
      • Table Glossary
    • About GlobalData
    • Contact Us
    • Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings